J. W. Foppe van Mil
Research Subjects
Research Interests
J. W. Foppe van Mil has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Martin Charles Henman
Trinity College Dublin, Dublin, Ireland
4 shared publications James McElnay
Queens University, Belfast, N. Ireland, UK
3 shared publications- Kurt E. Hersberger
Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
3 shared publications Kurt E Hersberger
Pharmacist Institut für Klinische Pharmazie Universität Basel Basel, Switzerland
2 shared publications- Lawrence M. Brown
Chapman University
2 shared publications Lo Tommy Westerlund
Research Pharmacist National Corporation of Swedish Pharmacies Apoteket Bjornen Helsingborg, Sweden
2 shared publications
Latest Publications
- 21 November 2019
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 41 (6) , 1391-1393
Seamless care, do it well or not at all
- 21 November 2019
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 41 (6) , 1391-1393
Seamless care, do it well or not at all
- 1 April 2019
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 41 (2) , 385-386
Open access, at what costs?
- 1 April 2019
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 41 (2) , 385-386
Open access, at what costs?
- 5 March 2019
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 41 (2) , 589-592
Thank you to the reviewers 2018
- 5 March 2019
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 41 (2) , 589-592
Thank you to the reviewers 2018
- Open Access
- 2 November 2018
- Published by Springer Nature
- p. E1
Correction to: The Pharmacist Guide to Implementing Pharmaceutical Care
- 2 November 2018
- Published by Springer Nature
- p. E1
Open AccessCorrection to: The Pharmacist Guide to Implementing Pharmaceutical Care
- Top Cited Papers
- 2 August 2018
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 40 (5) , 1199-1208
PCNE definition of medication review: reaching agreement
Background Medication review is important in an era, in which polypharmacy is increasing. To date, no agreed international definition of medication review exists. Objective The aim was to reach agreement on an internationally applicable definition of medication review. Setting An international group of experts in medication review. Methods A working group of the Pharmaceutical Care Network Europe (PCNE) was established to agree on a definition including a classification of medication review. First, a survey with the aim of systematically gathering viewpoints on a definition of medication review was conducted. Second, a workshop was held to achieve an agreement. Finally, during the General Assembly of PCNE, the definition was approved. To ensure a better understanding of the scope and the considerations behind the definition, a position paper was created. Main outcome measure An internationally agreed definition of medication review. Results 58 PCNE members from 20 different countries completed the online survey. Then, 22 participants from 11 different countries (not only PCNE members) elaborated the final definition during a workshop. The final PCNE version agreed was: “Medication review is a structured evaluation of a patient’s medicines with the aim of optimising medicines use and improving health outcomes. This entails detecting drug-related problems and recommending interventions”. Overall, the consensus process included 225 people from 35 countries and resulted also in a classification of medication review taking into account the type and source of available information. Conclusion Involvement of an international community from research and practice and the use of a systematic process led to an agreement on the term medication review and on a classification valid for all settings and professions.
- 2 August 2018
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 40 (5) , 1199-1208
Top Cited PapersPCNE definition of medication review: reaching agreement
Background Medication review is important in an era, in which polypharmacy is increasing. To date, no agreed international definition of medication review exists. Objective The aim was to reach agreement on an internationally applicable definition of medication review. Setting An international group of experts in medication review. Methods A working group of the Pharmaceutical Care Network Europe (PCNE) was established to agree on a definition including a classification of medication review. First, a survey with the aim of systematically gathering viewpoints on a definition of medication review was conducted. Second, a workshop was held to achieve an agreement. Finally, during the General Assembly of PCNE, the definition was approved. To ensure a better understanding of the scope and the considerations behind the definition, a position paper was created. Main outcome measure An internationally agreed definition of medication review. Results 58 PCNE members from 20 different countries completed the online survey. Then, 22 participants from 11 different countries (not only PCNE members) elaborated the final definition during a workshop. The final PCNE version agreed was: “Medication review is a structured evaluation of a patient’s medicines with the aim of optimising medicines use and improving health outcomes. This entails detecting drug-related problems and recommending interventions”. Overall, the consensus process included 225 people from 35 countries and resulted also in a classification of medication review taking into account the type and source of available information. Conclusion Involvement of an international community from research and practice and the use of a systematic process led to an agreement on the term medication review and on a classification valid for all settings and professions.
- 1 October 2017
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 39 (5) , 977-979
Citations and science
- 1 October 2017
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 39 (5) , 977-979
Citations and science
- 24 January 2017
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 39 (1) , 205-207
Thank you to the reviewers
- 24 January 2017
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 39 (1) , 205-207
Thank you to the reviewers
- 30 May 2016
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 38 (4) , 1003-1004
Stockley’s drug interactions 11th edition
- 30 May 2016
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 38 (4) , 1003-1004
Stockley’s drug interactions 11th edition
- 19 May 2016
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 38 (4) , 1002
Safety in medication use
- 19 May 2016
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 38 (4) , 1002
Safety in medication use
- 12 April 2016
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 38 (3) , 709-713
Terminology, the importance of defining
Multiple terms and definitions exist to describe specific aspects of pharmacy practice and service provision. This commentary explores the reasons for different interpretations of words and concepts in pharmaceutical care and pharmacy practice research. Reasons for this variation can be found in language, culture, profession and may also depend on developments over time. A list of words is provided where the authors think that currently multiple interpretations are possible. To make sure that the reader understands the essence, it seems imperative that authors include a definition of the topics that they actually study in their papers, and that they clearly cite existing definitions or refer to collections of definitions such as existing glossaries. It is important that presenters, authors and reviewers of pharmacy practice papers pay more attention to this aspect of describing studies.
- 12 April 2016
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 38 (3) , 709-713
Terminology, the importance of defining
Multiple terms and definitions exist to describe specific aspects of pharmacy practice and service provision. This commentary explores the reasons for different interpretations of words and concepts in pharmaceutical care and pharmacy practice research. Reasons for this variation can be found in language, culture, profession and may also depend on developments over time. A list of words is provided where the authors think that currently multiple interpretations are possible. To make sure that the reader understands the essence, it seems imperative that authors include a definition of the topics that they actually study in their papers, and that they clearly cite existing definitions or refer to collections of definitions such as existing glossaries. It is important that presenters, authors and reviewers of pharmacy practice papers pay more attention to this aspect of describing studies.